MYZOLIX CV DRY SYRUP
-
Cefixime 50 mg + Potassium Clavulanate 31.25 mg Dry Syrup is a broad-spectrum antibiotic formulation designed for children.
-
Cefixime: A third-generation cephalosporin antibiotic that kills bacteria by inhibiting cell wall synthesis.
-
Potassium Clavulanate: A beta-lactamase inhibitor that prevents resistant bacteria from destroying Cefixime, thus enhancing its effectiveness.
-
Supplied in dry syrup form, ensuring accurate and easy administration in pediatric patients.
This combination is prescribed for treating moderate to severe bacterial infections, especially when drug resistance is suspected, such as:
-
Respiratory tract infections – pneumonia, bronchitis, sinusitis, pharyngitis, tonsillitis
-
Ear infections (otitis media)
-
Urinary tract infections (UTIs)
-
Skin and soft tissue infections
-
Typhoid fever (enteric fever) in children (as advised by doctor)
-
Infections caused by beta-lactamase–producing resistant bacteria